相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Tracking Innate Immune Activation in a Mouse Model of Parkinson's Disease Using TREM1 and TSPO PET Tracers
Katherine L. Lucot et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches
Nicolaas I. Bohnen et al.
LANCET NEUROLOGY (2022)
Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
Ruiqing Ni et al.
FRONTIERS IN AGING NEUROSCIENCE (2022)
Dopaminergic Positron Emission Tomography Imaging in the Alpha-Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
Vesna Sossi et al.
MOVEMENT DISORDERS (2022)
Cerebral metabolic pattern associated with progressive parkinsonism in non-human primates reveals early cortical hypometabolism
Francisco Molinet-Dronda et al.
NEUROBIOLOGY OF DISEASE (2022)
In vivo imaging of alpha-synuclein with antibody-based PET
Sahar Roshanbin et al.
NEUROPHARMACOLOGY (2022)
Pathophysiological significance of increased α-synuclein deposition in sympathetic nerves in Parkinson's disease: a post-mortem observational study
Risa Isonaka et al.
TRANSLATIONAL NEURODEGENERATION (2022)
Recent Technical Advances in Accelerating the Clinical Translation of Small Animal Brain Imaging: Hybrid Imaging, Deep Learning, and Transcriptomics
Wuwei Ren et al.
FRONTIERS IN MEDICINE (2022)
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's disease
Danna Jennings et al.
SCIENCE TRANSLATIONAL MEDICINE (2022)
Structures of α-synuclein filaments from human brains with Lewy pathology
Yang Yang et al.
NATURE (2022)
The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils
Leif Antonschmidt et al.
NATURE COMMUNICATIONS (2022)
Evidence of distinct α-synuclein strains underlying disease heterogeneity
Sara A. M. Holec et al.
ACTA NEUROPATHOLOGICA (2021)
In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET
Majken B. Thomsen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2021)
18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging
Ryuichi Harada et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
First-in-Human Evaluation of 18F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A
Mika Naganawa et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
PET Imaging of VMAT2 with the Novel Radioligand [18F]FE-DTBZ-d4 in Nonhuman Primates: Comparison with [11C]DTBZ and [18F]FE-DTBZ
Sangram Nag et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Novel Positron Emission Tomography Radiotracers for Imaging Mitochondrial Complex I
Yulong Xu et al.
ACS CHEMICAL NEUROSCIENCE (2021)
[11C]MODAG-001-towards a PET tracer targeting α-synuclein aggregates
Laura Kuebler et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
From iPS Cells to Rodents and Nonhuman Primates: Filling Gaps in Modeling Parkinson's Disease
Tiago F. Outeiro et al.
MOVEMENT DISORDERS (2021)
Viral-based rodent and nonhuman primate models of multiple system atrophy: Fidelity to the human disease
David J. Marmion et al.
NEUROBIOLOGY OF DISEASE (2021)
Parkinson's disease outside the brain: targeting the autonomic nervous system
Yehonatan Sharabi et al.
LANCET NEUROLOGY (2021)
Development and biological evaluation of[18F]FMN3PA & [18F] FMN3PU for leucine-rich repeat kinase 2 (LRRK2) in vivo PET imaging
Noeen Malik et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
18F-Labelled pyrrolopyrimidines reveal brain leucine-rich repeat kinase 2 expression implicated in Parkinson's disease
Xueyuan Chen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Monitoring of a progressive functional dopaminergic deficit in the A53T-AAV synuclein rats by combining 6-[18F]fluoro-L-m-tyrosine imaging and motor performances analysis
Guillaume Becker et al.
NEUROBIOLOGY OF AGING (2021)
In vivo imaging of synaptic density with [11C]UCB-J PET in two mouse models of neurodegenerative disease
Mengfei Xiong et al.
NEUROIMAGE (2021)
Autologous transplant therapy alleviates motor and depressive behaviors in parkinsonian monkeys
Yunlong Tao et al.
NATURE MEDICINE (2021)
PET imaging reveals early and progressive dopaminergic deficits after intra-striatal injection of preformed alpha-synuclein fibrils in rats
Majken B. Thomsen et al.
NEUROBIOLOGY OF DISEASE (2021)
Synthesis and pharmacokinetic characterisation of a fluorine-18 labelled brain shuttle peptide fusion dimeric affibody
Takahiro Morito et al.
SCIENTIFIC REPORTS (2021)
Microglia-specific overexpression of α-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity
Simone Bido et al.
NATURE COMMUNICATIONS (2021)
In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer's Brain Tissue
Ruiqing Ni et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Early atypical signs and insula hypometabolism predict survival in multiple system atrophy
Stephan Grimaldi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
Neuroprotection of Exendin-4 by Enhanced Autophagy in a Parkinsonian Rat Model of α-Synucleinopathy
Lu-Lu Bu et al.
NEUROTHERAPEUTICS (2021)
Synaptic Density and Neuronal Metabolic Function Measured by Positron Emission Tomography in the Unilateral 6-OHDA Rat Model of Parkinson's Disease
Nakul Ravi Raval et al.
FRONTIERS IN SYNAPTIC NEUROSCIENCE (2021)
Towards PET imaging of the dynamic phenotypes of microglia
Wissam Beaino et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2021)
[18F]FDG PET/CT Studies in Transgenic Hualpha-Syn (A53T) Parkinson's Disease Mouse Model of α-Synucleinopathy
Rommani Mondal et al.
FRONTIERS IN NEUROSCIENCE (2021)
Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [18F]ASEM in a Rat Model of Parkinson's Disease
Steven Vetel et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development
Stuart P. McCluskey et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Imaging SERT Availability in a Rat Model of L-DOPA-Induced Dyskinesia
Michael Walker et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
Evaluation of the Neuroprotective Effect of Microglial Depletion by CSF-1R Inhibition in a Parkinson's Animal Model
Se Jong Oh et al.
MOLECULAR IMAGING AND BIOLOGY (2020)
Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy
Mohammad Shahnawaz et al.
NATURE (2020)
LRRK2 in Parkinson disease: challenges of clinical trials
Eduardo Tolosa et al.
NATURE REVIEWS NEUROLOGY (2020)
In vivo mitochondrial and glycolytic impairments in patients with Alzheimer disease
Tatsuhiro Terada et al.
NEUROLOGY (2020)
The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
Anne-Laure Mahul-Mellier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
[18F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration
Tatiana Rodriguez-Chinchilla et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Confirmation of 123I-FP-CIT SPECT Quantification Methods in Dementia with Lewy Bodies and Other Neurodegenerative Disorders
Daniela D. Maltais et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Structures of α-synuclein filaments from multiple system atrophy
Manuel Schweighauser et al.
NATURE (2020)
Snca-GFP knock-in mice reflect patterns of endogenous expression and pathological seeding
Anna Caputo et al.
eNeuro (2020)
Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study
Jacob Horsager et al.
BRAIN (2020)
Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson's disease
Julian L. Goggi et al.
STEM CELL RESEARCH & THERAPY (2020)
Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series
Valerie Joers et al.
NEUROBIOLOGY OF DISEASE (2020)
PET imaging with [18F]FP-(+)-DTBZ in 6-OHDA-induced partial and full unilaterally-lesioned model rats of Parkinson's disease and the correlations to the biological data
Jie Tang et al.
NUCLEAR MEDICINE AND BIOLOGY (2020)
Radiosynthesis and evaluation of 4-(6-[18F]Fluoro-4-(5-isopropoxy-1H-indazol-3-yl)pyridin-2-yl)morpholine as a novel radiotracer candidate targeting leucine-rich repeat kinase 2
Wakana Mori et al.
RSC MEDICINAL CHEMISTRY (2020)
Evaluation of exercise-induced modulation of glial activation and dopaminergic damage in a rat model of Parkinson's disease using [11C]PBR28 and [18F]FDOPA PET
Caroline C. Real et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2019)
PET imaging of the influence of physiological and pathological α-synuclein on dopaminergic and serotonergic neurotransmission in mouse models
Elise Levigoureux et al.
CNS NEUROSCIENCE & THERAPEUTICS (2019)
Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers
Cristian C. Constantinescu et al.
MOLECULAR IMAGING AND BIOLOGY (2019)
PET imaging of dopamine release in the frontal cortex of manganese-exposed non-human primates
Tomas R. Guilarte et al.
JOURNAL OF NEUROCHEMISTRY (2019)
[18F]Fluoroethoxybenzovesamicol in Parkinson's disease patients: Quantification of a novel cholinergic positron emission tomography tracer
Sygrid van der Zee et al.
MOVEMENT DISORDERS (2019)
Oral and intravenous transmission of α-synuclein fibrils to mice
Stephanie Lohmann et al.
ACTA NEUROPATHOLOGICA (2019)
Synthesis and Preliminary Evaluation of [11C]GNE-1023 as a Potent PET Probe for Imaging Leucine-Rich Repeat Kinase 2 (LRRK2) in Parkinson's Disease
Zhen Chen et al.
CHEMMEDCHEM (2019)
Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice
Diana Matheoud et al.
NATURE (2019)
Transneuronal Propagation of Pathologic α-Synuclein from the Gut to the Brain Models Parkinson's Disease
Sangjune Kim et al.
NEURON (2019)
Effect of genotype and age on cerebral [18F]FDG uptake varies between transgenic APPswe-PS1dE9 and Tg2576 mouse models of Alzheimer's disease
Anniina Snellman et al.
SCIENTIFIC REPORTS (2019)
Imidazoline 2 binding sites reflecting astroglia pathology in Parkinson's disease: an in vivo 11C-BU99008 PET study
Heather Wilson et al.
BRAIN (2019)
Believing in dopamine
Samuel J. Gershman et al.
NATURE REVIEWS NEUROSCIENCE (2019)
Development of a novel radioligand for imaging 18-kD translocator protein (TSPO) in a rat model of Parkinson's disease
Chun-Yi Wu et al.
BMC MEDICAL IMAGING (2019)
Increased P2X7 Receptor Binding Is Associated With Neuroinflammation in Acute but Not Chronic Rodent Models for Parkinson's Disease
Melissa Crabbe et al.
FRONTIERS IN NEUROSCIENCE (2019)
Voluntary exercise delays progressive deterioration of markers of metabolism and behavior in a mouse model of Parkinson's disease
Jing-Huei Lai et al.
BRAIN RESEARCH (2019)
Temporal changes in neuroinflammation and brain glucose metabolism in a rat model of viral vector-induced α-synucleinopathy
Melissa Crabbe et al.
EXPERIMENTAL NEUROLOGY (2019)
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease (vol 10, 3945, 2019)
Paraskevi Krashia et al.
NATURE COMMUNICATIONS (2019)
Synthesis and in Vivo Evaluation of a Novel PET Radiotracer for Imaging of Synaptic Vesicle Glycoprotein 2A (SV2A) in Nonhuman Primates
Songye Li et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Identifying a glucose metabolic brain pattern in an adeno-associated viral vector based rat model for Parkinson's disease using 18F-FDG PET imaging
Martijn Devrome et al.
SCIENTIFIC REPORTS (2019)
PET imaging of [11C]PBR28 in Parkinson's disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
Katarina Varnas et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
A non-human primate model for stable chronic Parkinson's disease induced by MPTP administration based on individual behavioral quantification
Jincheol Seo et al.
JOURNAL OF NEUROSCIENCE METHODS (2019)
Extensive exploration of a novel rat model of Parkinson's disease using partial 6-hydroxydopamine lesion of dopaminergic neurons suggests new therapeutic approaches
Steven Vetel et al.
SYNAPSE (2019)
Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis
Michaela E. Johnson et al.
TRENDS IN NEUROSCIENCES (2019)
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration
Megan F. Duffy et al.
JOURNAL OF NEUROINFLAMMATION (2018)
In Silico, in Vitro, and in Vivo Evaluation of New Candidates for α-Synuclein PET Imaging
Mathieu Verdurand et al.
MOLECULAR PHARMACEUTICS (2018)
In vivo quantification of glial activation in minipigs overexpressing human alpha-synuclein
Thea Pinholt Lillethorup et al.
SYNAPSE (2018)
Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
E. Ray Dorsey et al.
LANCET NEUROLOGY (2018)
Cholinergic PET imaging in infections and inflammation using 11C-donepezil and 18F-FEOBV
Nis Pedersen Jorgensen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinal 18F-FDG and 18F-DPA-714 PET imaging
Jatta S. Takkinen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Metabolic Imaging in Parkinson Disease
Sanne K. Meles et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys
Masakatsu Kanazawa et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study
Morten Gersel Stokholm et al.
LANCET NEUROLOGY (2017)
Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia
X. Zhou et al.
NEUROIMAGE (2017)
Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9fluoropropyl-(+)-dihydrotetrabenazine PET imaging
Chi-Chang Weng et al.
PLOS ONE (2017)
Modeling Parkinson's disease pathology by combination of fibril seeds and α-synuclein overexpression in the rat brain
Poonam Thakur et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Microglial phenotypes in Parkinson's disease and animal models of the disease
Valerie Joers et al.
PROGRESS IN NEUROBIOLOGY (2017)
The Role of Astrocyte Dysfunction in Parkinson's Disease Pathogenesis
Heather D. E. Booth et al.
TRENDS IN NEUROSCIENCES (2017)
Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease
Jenny-Ann Phan et al.
SCIENTIFIC REPORTS (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Propagation of pathological α-synuclein in marmoset brain
Aki Shimozawa et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Synthesis of [11C]HG-10-102-01 as a new potential PET agent for imaging of LRRK2 enzyme in Parkinson's disease
Min Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice
Michael Walker et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis
Inga B. Fricke et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2016)
In Vivo Imaging of Microglial Activation by Positron Emission Tomography with [11C] PBR28 in the 5XFAD Model of Alzheimer's Disease
Nazanin Mirzaei et al.
GLIA (2016)
Dynamic Changes in Striatal mGluR1 But Not mGluR5 during Pathological Progression of Parkinson's Disease in Human Alpha-Synuclein A53T Transgenic Rats: A Multi-PET Imaging Study
Tomoteru Yamasaki et al.
JOURNAL OF NEUROSCIENCE (2016)
Imaging Dopamine and Serotonin Systems on MPTP Monkeys: A Longitudinal PET Investigation of Compensatory Mechanisms
Benedicte Ballanger et al.
JOURNAL OF NEUROSCIENCE (2016)
Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple-Tracer PET Study
Matthias Brendel et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
PET Imaging of Mitochondrial Complex I with 18F-BCPP-EF in the Brains of MPTP-Treated Monkeys
Hideo Tsukada et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Dissociation of metabolic and hemodynamic levodopa responses in the 6-hydroxydopamine rat model
Renata P. Lerner et al.
NEUROBIOLOGY OF DISEASE (2016)
Functional modulation of G-protein coupled receptors during Parkinson disease-like neurodegeneration
Bruce G. Jenkins et al.
NEUROPHARMACOLOGY (2016)
PET imaging of dopamine transporters with [18F]FE-PE2I: Effects of anti-Parkinsonian drugs
Ji-In Bang et al.
NUCLEAR MEDICINE AND BIOLOGY (2016)
Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study
Elena Rodriguez-Vieitez et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Therapeutic potentials of human adipose-derived stem cells on the mouse model of Parkinson's disease
Hee Soon Choi et al.
NEUROBIOLOGY OF AGING (2015)
Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: A longitudinal in-vivo study
Francisco Molinet-Dronda et al.
NEUROBIOLOGY OF DISEASE (2015)
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson's Disease
Alicia M. Pickrell et al.
NEURON (2015)
Relationship between dopamine deficit and the expression of depressive behavior resulted from alteration of serotonin system
Minkyung Lee et al.
SYNAPSE (2015)
Progressive Aggregation of Alpha-Synuclein and Selective Degeneration of Lewy Inclusion-Bearing Neurons in a Mouse Model of Parkinsonism
Valerie R. Osterberg et al.
CELL REPORTS (2015)
Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET
Trine Gjerloff et al.
BRAIN (2015)
Assessment of the protection of dopaminergic neurons by an alpha 7 nicotinic receptor agonist, PHA 543613 using [F-18]LBT-999 in a Parkinson's disease rat model
Sophie Serriere et al.
FRONTIERS IN MEDICINE (2015)
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys
Ariadna Recasens et al.
ANNALS OF NEUROLOGY (2014)
Synthesis and Biological Evaluation of 10-11C-Dihydrotetrabenazine as a Vesicular Monoamine Transporter 2 Radioligand
Xiaomin Li et al.
ARCHIV DER PHARMAZIE (2014)
Neuroimaging in Parkinson disease: from research setting to clinical practice
Marios Politis
NATURE REVIEWS NEUROLOGY (2014)
Differential Dopamine Receptor Occupancy Underlies L-DOPA-Induced Dyskinesia in a Rat Model of Parkinson's Disease
Gurdal Sahin et al.
PLOS ONE (2014)
Behavioral Deficits and Striatal DA Signaling in LRRK2 p.G2019S Transgenic Rats: A Multimodal Investigation Including PET Neuroimaging
Matthew D. Walker et al.
JOURNAL OF PARKINSONS DISEASE (2014)
A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats
Silke Nuber et al.
BRAIN (2013)
PET Imaging of Serotonin Transporters With 4-[18F]-ADAM in a Parkinsonian Rat Model
Shao-Ju Weng et al.
CELL TRANSPLANTATION (2013)
Expression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment
Jason R. Cannon et al.
EXPERIMENTAL NEUROLOGY (2013)
AAV2-mediated striatum delivery of human CDNF prevents the deterioration of midbrain dopamine neurons in a 6-hydroxydopamine induced parkinsonian rat model
Xinmiao Ren et al.
EXPERIMENTAL NEUROLOGY (2013)
In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [F-18]FDOPA PET
Matthew D. Walker et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2013)
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP
Christian Hansen et al.
NEUROBIOLOGY OF DISEASE (2013)
Construction and Evaluation of Quantitative Small-Animal PET Probabilistic Atlases for [18F]FDG and [18F]FECT Functional Mapping of the Mouse Brain
Cindy Casteels et al.
PLOS ONE (2013)
In Vivo Visualization and Monitoring of Viable Neural Stem Cells Using Noninvasive Bioluminescence Imaging in the 6-Hydroxydopamine-Induced Mouse Model of Parkinson Disease
Hyung-Jun Im et al.
MOLECULAR IMAGING (2013)
Evaluation of dopamine transporters and D2 receptors in hemiparkinsonian rat brains in vivo using consecutive PET scans of [18F]FPCIT and [18F]fallypride
Jae Yong Choi et al.
APPLIED RADIATION AND ISOTOPES (2012)
Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism
Yilong Ma et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
In Vivo Dopamine Transporter Imaging in a Unilateral 6-Hydroxydopamine Rat Model of Parkinson Disease Using 11C-Methylphenidate PET
Vesna Sossi et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Imaging DA release in a rat model of L-DOPA-induced dyskinesias: A longitudinal in vivo PET investigation of the antidyskinetic effect of MDMA
Nadine Y. Lettfuss et al.
NEUROIMAGE (2012)
[18F]desmethoxyfallypride as a novel PET radiotracer for quantitative in vivo dopamine D2/D3 receptor imaging in rat models of neurodegenerative diseases
Mate D. Doebroessy et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
PET Imaging a MPTP-Induced Mouse Model of Parkinson's Disease Using the Fluoropropyl-Dihydrotetrabenazine Analog [18F]-DTBZ (AV-133)
James S. Toomey et al.
PLOS ONE (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
E46K Human α-Synuclein Transgenic Mice Develop Lewy-like and Tau Pathology Associated with Age-dependent, Detrimental Motor Impairment
Kristel L. Emmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Striatal adenosine A2A receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [18F]-MRS5425
Abesh Kumar Bhattacharjee et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
David Ramonet et al.
PLOS ONE (2011)
In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson's disease
Cindy Casteels et al.
BRAIN RESEARCH (2010)
Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC
Piotr Hadaczek et al.
MOLECULAR THERAPY (2010)
Exercise Elevates Dopamine D2 Receptor in a Mouse Model of Parkinson's Disease: In Vivo Imaging with [18F]Fallypride
Marta G. Vuckovic et al.
MOVEMENT DISORDERS (2010)
In vivo studies of the SERT-selective [18F]FPBM and VMAT2-selective [18F]AV-133 radiotracers in a rat model of Parkinson's disease
Julie L. Wang et al.
NUCLEAR MEDICINE AND BIOLOGY (2010)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET
Sriram Venneti et al.
NEUROBIOLOGY OF AGING (2009)
VMAT2 and dopamine neuron loss in a primate model of Parkinson's disease
Ming-Kai Chen et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease
Cindy Casteels et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography
Jun Maeda et al.
JOURNAL OF NEUROSCIENCE (2007)
Modulation of dopaminergic and glutamatergic brain function: PET studies on Parkinsonian rats
Daniela Pellegrino et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility
Yilong Ma et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Protocol for the MPTP mouse model of Parkinson's disease
Vernice Jackson-Lewis et al.
NATURE PROTOCOLS (2007)
A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation
Sriram Venneti et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Genetics of Parkinson disease: paradigm shifts and future prospects
MJ Farrer
NATURE REVIEWS GENETICS (2006)
Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: A multi-tracer PET study
DJ Doudet et al.
NEUROIMAGE (2006)
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
BA Lynch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
In vivo PET imaging of gene expression in parkinsonian monkeys
JL Eberling et al.
MOLECULAR THERAPY (2003)
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy
A Gerhard et al.
NEUROLOGY (2003)
Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice
MK Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Differential neuropathological alterations in transgenic mice expressing α-synuclein from the platelet-derived growth factor and Thy-1 promoters
E Rockenstein et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2002)
Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP-treated monkeys:: PET studies with [11C]raclopride
DJ Doudet et al.
SYNAPSE (2002)
Neuronal α-synucleinopathy with severe movement disorder in mice expressing A53T human α-synuclein
BI Giasson et al.
NEURON (2002)
Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging
F Cicchetti et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2002)
Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter
Y Matsuoka et al.
NEUROBIOLOGY OF DISEASE (2001)
Neuropathology in mice expressing human α-synuclein
H van der Putten et al.
JOURNAL OF NEUROSCIENCE (2000)
Dopaminergic loss and inclusion body formation in α-synuclein mice:: Implications for neurodegenerative disorders
E Masliah et al.
SCIENCE (2000)